Streetbeat News

Analyst Ratings

POR

Mizuho analyst Anthony Crowdell maintains a Neutral rating on Portland General Electric (NYSE:POR) and raises the price target from $42 to $45.

Portfolio Pulse from Benzinga Newsdesk

May 16, 2024 | 11:16 am

NWE

Mizuho analyst Anthony Crowdell maintains a Neutral rating on NorthWestern Energy Group (NASDAQ:NWE) and raises the price target from $51 to $52.

Portfolio Pulse from Benzinga Newsdesk

May 16, 2024 | 11:14 am

INFN

Needham analyst Ryan Koontz has reiterated a Buy rating on Infinera (NASDAQ:INFN) and maintained a $10 price target.

Portfolio Pulse from Benzinga Newsdesk

May 16, 2024 | 11:14 am

IDA

Mizuho analyst Anthony Crowdell maintains a Neutral rating on Idacorp (NYSE:IDA) and raises the price target from $88 to $99.

Portfolio Pulse from Benzinga Newsdesk

May 16, 2024 | 11:13 am

CSCO

Needham analyst Alex Henderson has reiterated a Hold rating on Cisco Systems (NASDAQ:CSCO).

Portfolio Pulse from Benzinga Newsdesk

May 16, 2024 | 11:12 am

ALE

Mizuho analyst Anthony Crowdell maintains a Neutral rating on ALLETE (NYSE:ALE) and raises the price target from $57 to $67.

Portfolio Pulse from Benzinga Newsdesk

May 16, 2024 | 11:10 am

BRNS

HC Wainwright & Co. has reiterated its Buy rating on Barinthus Biotherapeutics (NASDAQ:BRNS) and maintained a price target of $8.

Portfolio Pulse from Benzinga Newsdesk

May 16, 2024 | 11:10 am

IMTX

Mizuho analyst Graig Suvannavejh maintains a Buy rating on Immatics (NASDAQ:IMTX) and raises the price target from $14 to $16.

Portfolio Pulse from Benzinga Newsdesk

May 16, 2024 | 11:09 am

ALIM

HC Wainwright & Co. analyst Yi Chen has reiterated a Buy rating on Alimera Sciences (NASDAQ:ALIM) and maintained a $6 price target.

Portfolio Pulse from Benzinga Newsdesk

May 16, 2024 | 11:08 am

OVID

HC Wainwright & Co. has reiterated its Buy rating on Ovid Therapeutics (NASDAQ:OVID) and maintained a price target of $9.

Portfolio Pulse from Benzinga Newsdesk

May 16, 2024 | 11:07 am